Survival in Patients With De Novo Metastatic Prostate Cancer

Schoen, Martin W.; Montgomery, R. Bruce; Owens, Lukas; Khan, Saira; Sanfilippo, Kristen M.; Etzioni, Ruth B.

doi:10.1001/jamanetworkopen.2024.1970

JAMA Netw Open

2024

DOI: 10.1001/jamanetworkopen.2024.1970

|View full text |Cite

Survival in Patients With De Novo Metastatic Prostate Cancer

Martin W. Schoen,

R. Bruce Montgomery,

Lukas Owens

et al.

Abstract: This cross-sectional study investigates trends in overall survival among patients with newly diagnosed metastatic prostate cancer in 2 national registries in the United States.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

2025

Publication Types

Select...

Article5

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 5 publications

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer

Tanegashima,

Shiota,

Terada

et al. 2024

Int J Clin Oncol

View full text Add to dashboard Cite

Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer

Tanegashima,

Shiota,

Terada

et al. 2024

Int J Clin Oncol

View full text Add to dashboard Cite

Cardiovascular Risk in Prostate Cancer

Leong,

Cirne,

Pinthus

2025

Cardiology Clinics

View full text Add to dashboard Cite

Treatment-related Hypertension as a Prognostic Factor for De Novo Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Real-world Evidence Study

Salfi,

Pedrani,

Candan

et al. 2025

European Urology Open Science

View full text Add to dashboard Cite

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Survival in Patients With De Novo Metastatic Prostate Cancer

Abstract: This cross-sectional study investigates trends in overall survival among patients with newly diagnosed metastatic prostate cancer in 2 national registries in the United States.

Cited by 5 publications

References 7 publications

Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer

Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer

Cardiovascular Risk in Prostate Cancer

Treatment-related Hypertension as a Prognostic Factor for De Novo Metastatic Hormone-sensitive Prostate Cancer: A Retrospective Real-world Evidence Study

Contact Info

Product

Resources

About